|

Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada

RECRUITINGN/ASponsored by University of British Columbia
Actively Recruiting
PhaseN/A
SponsorUniversity of British Columbia
Started2026-05-26
Est. completion2029-08-31
Eligibility
Age19 Years – 80 Years
Healthy vol.Accepted

Summary

Wildfire smoke (WFS) is the leading climate-related risk in Canada and the main source of harmful air pollution. While short-term breathing problems caused by smoke are well known, there is limited knowledge on how repeated exposure contributes to long-term lung disease. This study is a controlled human exposure to varying concentrations of WFS in a safe setting. By comparing the effects of different concentrations, this research will improve understanding of health impacts, identify who may be most vulnerable to exposures, and explore biological changes that could lead to chronic illness.

Eligibility

Age: 19 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Healthy Adults between the ages of 19 to 80 (12 of each biological sex assigned at birth).

Exclusion Criteria:

1. Current smoker (within six months before screening; potential to confound exposure effects).
2. History or current diagnosis of any respiratory conditions (including, but not limited to asthma or chronic obstructive pulmonary disease (COPD), asthma/COPD overlap) or other medical conditions that the study physician determines may impact participant safety.
3. Any comorbidities or other concerns identified by the study physician which may impact study participation.
4. For participants of child-bearing potential: Current pregnancy, or plans to become pregnant during study enrolment.

Conditions5

AsthmaCOPDCancerChronic Obstructive Pulmonary Disease (COPD)Lung Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.